Andres Deik, MD, MSEd
Neurology
Headshot of Andres Deik, MD, MSEd

Andres Deik, MD, MSEd

he/him/his
Neurology
Accepting new patients
Sees patients age 18 and up
Penn Neurology Pennsylvania Hospital
Headshot of Andres Deik, MD, MSEd
Penn Medicine Provider

About me

  • Director, Experimental Therapeutics
  • Director, Movement Disorders Fellowship Program
  • Professor of Clinical Neurology

My education and training

  • Beth Israel Medical CenterResidency
  • Beth Israel Medical CenterFellowship

Spoken languages

English
English
Español
Spanish

Reviews

Average Rating

730 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
September 2026
Excellent doctor
Anonymous
September 2026
I like the continuity of care since I have been seeing him for well over 10 years.
Anonymous
September 2026
Intake and scheduling next appointment were quick and easy
Anonymous
September 2026
Dr Deik is always professional, personable and knowledgeable, asking the right questions and likable. I have 6 physicians in my immediate family and have no problem with saying Dr Deik is one of the best doctors I have seen.

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
Dr. Deik is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

van der Stouwe M, Vermeulen O, Eggink W, Henriksen T, McGovern E, Smit M, Aybek S, Boon A, Brandsma R, Deik A, Erro R, Espay A, Falup-Pecurariu C, Frucht S, Ganos C, Gatto E, Helmich R, Klein C, Koelman H, Odekerken V, Koens L, Mahajan A, Morgante F, Münchau A, Panyakaew P, Peall K, Pérez-Dueñas B, Roze E, Sadnicka A, Schneider S, Schwingenschuh P, Serranova T, Skorvanek M, Stamelou M, Tamas G, Tinazzi M, Valadas A, Vandenberghe W, de Vries J, Zutt R, van der Veen S, Luiken R, Tuitert I, Tijssen M Defining the Clinical Phenotypic Ground Truth: Expert Interrater Agreement in Hyperkinetic Movement Disorders , Mov Disord Clin Pract: 2026


Yao D, Battistella G, Sharma N, et al. DystoniaDBSNet as a novel deep learning biomarker of predictive deep brain stimulation outcome in dystonia , npj Digit Med: 2026


Loaiza-Bonilla A, Arora P, Hayman N, Deik A A voice-biomarker foundation model for ALS monitoring and Parkinson’s screening , npj Digit Med: 2026


Friedman JH, Akbar U, Beehler B, Chou KL, Cloud LJ, Deik A, Gilbert R, Gomperts SN, Goudreau JL, Gunzler SA, Lizarraga K, Malaty I, Maurer CW, Miyasaki J, Mohammed N, Morgan JC, Munhoz RP, Pal G, Shulman L, Simon D, Pontone G. True vignettes: interesting, illustrative examples of behavioral abnormalities in people with Parkinson's disease , Arq Neuropsiquiatr, 84(5): 2026,1-6


Tropea, T.F., Stevenson, P.A., Flitter, M., Meehan, D., Morris, A., Lu, M., Iaccarino, L., Collins, E.C., Hodsdon, M.E., Irwin, D., Spindler, M., Deik, A., Dahodwala, N., Cousins, K.A.Q., Wolk, D.A., Shaw, L., Weintraub, D., Lee, E.B., Chen-Plotkin, A., Mintun, M. and Siderowf, A. (2026) Association between Plasma P-tau217 and Alzheimer's Copathology and Cognitive Decline in Parkinson's Disease. , Ann Neurol: 2026


Thomsen M, Ott F, Loens S, Kilic-Berkmen G, Tan AH, Lim SY, Lohmann E, Schröder KM, Ipsen L, Nothacker LA, Welzel L, Rudnik AS, Hinrichs F, Odorfer T, Zeuner KE, Schumann F, Kühn AA, Zittel S, Moeller M, Pfister R, Kamm C, Lang AE, Tay YW, de Almeida Marcelino AL, Vidailhet M, Roze E, Perlmutter JS, Feuerstein JS, Fung VSC, Chang F, Barbano RL, Bellows S, Wagle Shukla AA, Espay AJ, LeDoux MS, Berman BD, Reich S, Deik A, Franke A, Wittig M, Franzenburg S, Volkmann J, Brüggemann N, Jinnah HA, Bäumer T, Klein C, Busch H, Lohmann K. Genetic Diversity and Expanded Phenotypes in Dystonia: Insights From Large-Scale Exome Sequencing. , Ann Clin Transl Neurol, 12(8): 2025,1648-1659


Deik A, Aamodt W, Cadet C, Lasker A, Oliver A, Spindler M, Tropea T, Vaswani P, Siderowf A An open-label pilot study to examine the safety, tolerability and efficacy of deutetrabenazine in isolated dystonia , Movement Disorders Clinical Practice, 12(4): 2025,1-6


Tropea TF, Hartstone W, Amari N, Baum D, Rick J, Suh E, Zhang H, Paul RA, Han N, Zack R, Brody EM, Albuja I, James J, Spindler M, Deik A, Aamodt WW, Dahodwala N, Hamedani A, Lasker A, Hurtig H, Stern M, Weintraub D, Vaswani P, Willis AW, Siderowf A, Xie SX, Van Deerlin V, Chen-Plotkin AS Genetic and phenotypic characterization of Parkinson's disease at the clinic-wide level , NPJ Parkinsons Dis, 10(1): 2024,97


Beylergil SB, Mukunda KN, Elkasaby M, Perlmutter JS, Factor S, Bäumer T, Feurestein J, Shelton E, Bellows S, Jankovic J, Mahajan A, Wamer-Rosen T, Reich SG, Wagle Shukla A, Malady I, Espay A, Duque K, LeDoux MS, Saunders-Pullman R, Leaver K, Frank S, Pantelyat A, Fung V, Pirio Richardson S, Berman B, Stover N, Deik A, Ondo W, Groth C, Jinnah HA and Shaikh AG. Tremor in cervical dystonia , Dystonia: 2024,11309


Baldwin A, Copeland J, Azage M, Dratch L, Johnson K, Paul RA, Amado DA, Baer M, Deik A, Elman LB, Guo M, Hamedani AG, Irwin DJ, Lasker A, Orthmann-Murphy J, Quinn CC, Tropea TF, Scherer SS, Shinohara RT, Hamilton RH, Ellis CA. Disparities in Genetic Testing for Neurologic Disorders , Neurology, 102(6): 2024,e209161


View all publications